0

BMS 204352

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP187523359
CAS187523-35-9
Structure
MDL NumberMFCD09475617
Molecular Weight359.70
InChI KeyULYONBAOIMCNEH-HNNXBMFYSA-N
Description≥98% (HPLC)
SolubilityDMSO: 20 mg/mL, clear
Assay≥98% (HPLC)
Colorwhite to beige
Formpowder
Size5MG, 25MG
Storage Conditions−20°C
1

BMS-204352 (Bristol Myers Squibb)

K B Mackay

Curr Opin Investig Drugs. 2001 Jun;2(6):820-3.

PMID: 11572663

1

BMS-204352: A Potassium Channel Opener Developed for the Treatment of Stroke

Bo Skaaning Jensen

CNS Drug Rev. Winter 2002;8(4):353-60.

PMID: 12481191

1

In Vitro Protein Binding Studies With BMS-204352: Lack of Protein Binding Displacement Interaction in Human Serum

R Krishna, M Yao, D Kaczor, N Vachharajani, N R Srinivas

Biopharm Drug Dispos. 2001 Jan;22(1):41-4.

PMID: 11745906

1

KCNQ4 Channel Activation by BMS-204352 and Retigabine

R L Schrøder, T Jespersen, P Christophersen, D Strøbaek, B S Jensen, S P Olesen

Neuropharmacology. 2001 Jun;40(7):888-98.

PMID: 11378159

1

Voltage-independent KCNQ4 Currents Induced by (+/-)BMS-204352

Rikke Louise Schrøder, Dorte Strøbaek, Søren-Peter Olesen, Palle Christophersen

Pflugers Arch. 2003 Aug;446(5):607-16.

PMID: 12851819

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode